Boston Scientific completed the acquisition of Apollo Endosurgery for $615m.

Boston Scientific, a firm that develops, manufactures, and markets minimally invasive medical devices, completed the acquisition of Apollo Endosurgery, a firm active in the healthcare sector, for $615m. "Endoluminal surgery is an emerging field and a core focus for our Endoscopy business. We intend to expand our global capabilities in ELS with the differentiated innovation that Apollo Endosurgery offers, and we will continue to focus on procedural adoption as well as professional education in this exciting space. This acquisition also enables us to enter a new adjacency – the endobariatric market – and deliver strong, continued growth across our business," Mike Jones, Boston Scientific Senior Vice President.